NEW YORK--(BUSINESS WIRE)--Sept. 20, 2006--ZIOPHARM Oncology, Inc. (OTCBB: ZIOP.OB), a biopharmaceutical company focused on better cancer medicine, received approval of its application to list its common shares on the NASDAQ Capital Market. The Company’s common shares will begin trading on NASDAQ on Friday, September 22, 2006 under the symbol ZIOP. The trading of the Company’s shares on the Over-the-Counter Bulletin Board will cease on the close of business on Thursday, September 21, 2006.
